TrialBiopharmaceutics & drug disposition2018

Randomized, controlled study of bleselumab (ASKP1240) pharmacokinetics and safety in patients with moderate-to-severe plaque psoriasis.

Mysore S Anil Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.